Physician profile
Joon Lee
NPI 1366839458
$1,556.48
in general payments reported to CMS, 2019-2025
22 companies · $32.30 in 2025
The $32.30 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $199 · 2021: $181 · 2022: $305 · 2023: $294 · 2024: $348 · 2025: $32.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $434.93 | 2019-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $226.00 | 2020-2024 | Farxiga, Airsupra |
| Lilly USA, LLC | $148.95 | 2020-2024 | Mounjaro, Jardiance, Emgality |
| Valeritas, INC. | $109.70 | 2019 | |
| Nuwellis, INC. | $99.58 | 2020 | |
| Amgen INC. | $78.81 | 2019-2024 | Krystexxa |
| Pfizer INC. | $73.90 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.97 | 2020-2024 | Synjardy, Tradjenta, Jardiance |
| Exact Sciences Corporation | $49.71 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $38.86 | 2021-2023 | Pediarix, Bexsero |
| Novartis Pharmaceuticals Corporation | $32.22 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $27.71 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.29 | 2021-2022 | |
| Abbott Laboratories | $23.20 | 2023 | Freestyle Libre 3 |
| Esperion Therapeutics, INC. | $22.74 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $16.21 | 2023 | Quviviq |
| Genentech USA, INC. | $15.94 | 2019 | |
| Medline Industries LP | $14.94 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $14.37 | 2022 | |
| Abbvie INC. | $13.25 | 2021 | |
| Amarin Pharma, INC. | $12.72 | 2019 | |
| Astellas Pharma US INC | $12.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joon Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.